Effect of a costimulatory endodomain on the performance of T cells expressing CD19-directed chimeric antigen receptors (CARs) in subjects with relapsed/refractory B-cell malignancies

被引：0
|
作者：
Ramos, C. A.
Savoldo, B.
Liu, E.
Bollard, C. M.
Mims, M. P.
Keating, M. J.
Gee, A. P.
Mei, Z.
Rooney, C. M.
Heslop, H. E.
Brenner, M. K.
Dotti, G.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2541
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2541
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EFFECT OF A CO-STIMULATORY ENDODOMAIN ON THE PERFORMANCE OF T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AT CD19 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES
    Ramos, C. A.
    Savoldo, B.
    Liu, E.
    Bollard, C. M.
    Carrum, G.
    Kamble, R. T.
    Mims, M. P.
    Keating, M.
    Gee, A. P.
    Mei, Z.
    Rooney, C. M.
    Heslop, H. E.
    Brenner, M. K.
    Dotti, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S213 - S214
  • [2] How I treat refractory/relapsed diffuse large B-cell lymphomas with CD19-directed chimeric antigen receptor T cells
    Nagler, Arnon
    Perriello, Vincenzo Maria
    Falini, Lorenza
    Falini, Brunangelo
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (03) : 396 - 410
  • [3] Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
    Fang Bao
    Wei Wan
    Ting He
    Feifei Qi
    Guanghua Liu
    Kai Hu
    Xin-an Lu
    Ping Yang
    Fei Dong
    Jing Wang
    Hongmei Jing
    Cancer Gene Therapy, 2019, 26 : 248 - 255
  • [4] Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
    Bao, Fang
    Wan, Wei
    He, Ting
    Qi, Feifei
    Liu, Guanghua
    Hu, Kai
    Lu, Xin-an
    Yang, Ping
    Dong, Fei
    Wang, Jing
    Jing, Hongmei
    CANCER GENE THERAPY, 2019, 26 (7-8) : 248 - 255
  • [5] Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)-expressing T cells
    Mikhailova, Ekaterina
    Illarionova, Olga
    Shelikhova, Larisa
    Zerkalenkova, Elena
    Molostova, Olga
    Olshanskaya, Yulia
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    Popov, Alexander
    HAEMATOLOGICA, 2022, 107 (04) : 970 - 974
  • [6] T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies
    Li, Chunrui
    Wang, Qiuxiang
    Zhu, Hui
    Mao, Xia
    Wang, Ying
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2018, 132
  • [7] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Guoqing Wei
    Lijuan Ding
    Jiasheng Wang
    Yongxian Hu
    He Huang
    Experimental Hematology & Oncology, 6
  • [8] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    James N. Kochenderfer
    Steven A. Rosenberg
    Nature Reviews Clinical Oncology, 2013, 10 : 267 - 276
  • [9] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    Kochenderfer, James N.
    Rosenberg, Steven A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (05) : 267 - 276
  • [10] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Wei, Guoqing
    Ding, Lijuan
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
12345